Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Vasculitis

Northwestern UniversitySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Vasculitis cohort.

Asset / SponsorPhaseRating
Infliximab
University of California, San Francisco
Phase 1/2CCC
Bcma Car T Cells
Zhejiang University
Early Phase 1C

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →